Pavandeep Gill

Dr. Pavandeep Gill

University of British Columbia Hospital, Vancouver, British Columbia, Canada
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
PGPavandeep Gill
Pavandeep Gill
VPVictor G Prieto
Victor G Prieto
MAMary T. Austin
Mary T. Austin
Alessio GiubellinoAlessio Giubellino
Alessio Giubellino
Carlos Antonio Torres-CabalaCarlos Antonio Torres-Cabala
Carlos Antonio Torres-Cabala

1 September 2019 in Applied Immunohistochemistry & Molecular Morphology
Verified
Journal Article
Closed access
PGPavandeep Gill
Pavandeep Gill
CNChristopher Naugler
Christopher Naugler
MDMarie S. Md Abi Daoud
Marie S. Md Abi Daoud
Ber-EP4 has been the traditional immunostain used for the detection of basaloid skin tumors. Recently, MOC-31 has shown be superior to Ber-EP4 in the detection of basosquamous basal cell carcinoma (BCC) and many centers are now using both Ber-EP4 and MOC-31 antibodies together to detect these lesions. The objective of this study was to compare the utility of using both Ber-EP4 and MOC-31 immunostains in the detection of basaloid skin tumors and to better characterize the previously unknown staining properties of MOC-31 in cutaneous lesions. To do this, 76 basaloid skin tumors stained with both Ber-EP4 and MOC-31 were obtained. Diagnoses included basosquamous BCC, Merkel cell carcinoma, adenoid cystic carcinoma, microcystic adnexal carcinoma, sebaceous carcinoma, trichoepithelioma, trichoblastoma, sebaceous adenoma, sebaceoma, and follicular induction overlying dermatofibroma. The distribution and intensity of Ber-EP4 and MOC-31 staining in these lesions was scored. These scores were analyzed using a truth table, χ2 test, and Pearson correlation tests. The overall mean and SD of the scores were also obtained. Overall, we found Ber-EP4 and MOC-31 to be statistically equivalent immunostains for the diagnosis of basaloid skin tumors. We recommend the use of only one of these antibodies and favor MOC-31 for the detection of basaloid skin tumors. We also describe MOC-31 staining properties in different cutaneous lesions.

17 July 2015 in CMAJ Open
Verified
Journal Article
Open access
PDF file
PGPavandeep Gill
Pavandeep Gill
SKSunil Kalia
Sunil Kalia
Background Endogenous vitamin D synthesis can be affected by a number of variables, including skin colour, amount of skin exposed and levels of ultraviolet radiation. The objective of this study was to assess the feasibility of using only sunlight exposure in Canada to meet the daily recommended level of vitamin D, given differences in these variables and adherence to guidelines for sun protection. Methods Ultraviolet index data for 13 Canadian sites were obtained from Environment Canada. The sun exposure times required to synthesize 1000 IU of vitamin D in fair- and dark-skinned people who exposed either 1/4 or 1/8 of their body surface area to the sun were calculated for each hour of the year. These times were then classified according to whether the ultraviolet index was 3 or more (when sun protection is advised) or less than 3. Results During the fall and winter months and in the more northern sites, ultraviolet radiation levels were too low for all skin types to use sun exposure alone to obtain enough vitamin D within one time period. The required exposure time became longer when a smaller surface area was exposed. For people with darker skin, it can be difficult even in the summer to find opportunities outside of when sun protection is advised to use sunlight to obtain the recommended dose of vitamin D. Interpretation Although sun exposure is an important source of vitamin D, Canadians should look to other safe sources to meet the body’s vitamin D requirements throughout the year.

9 December 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
RSRiyad N. H. Seervai
Riyad N. H. Seervai
MHMeghan Heberton
Meghan Heberton
Woo Cheal ChoWoo Cheal Cho
Woo Cheal Cho
PGPavandeep Gill
Pavandeep Gill
MMMariela B. Murphy
Mariela B. Murphy
JCJonathan L. Curry
Jonathan L. Curry

28 January 2022 in Dermatopathology
Verified
Journal Article
Open access
PDF file
AMAustinn C. Miller
Austinn C. Miller
SASusuana Adjei
Susuana Adjei
LTLaurie A. Temiz
Laurie A. Temiz
PGPavandeep Gill
Pavandeep Gill
ASAlfredo Siller
Alfredo Siller
STStephen Tyring
Stephen Tyring
Poromas or poroid tumors are a group of rare, benign cutaneous neoplasms derived from the terminal eccrine or apocrine sweat gland duct. There are four poroma variants with overlapping features: dermal duct tumor (DDT), eccrine poroma, hidroacanthoma simplex, and poroid hidradenoma, of which DDT is the least common. Clinically, the variants have a nonspecific appearance and present as solitary dome-shaped papules, plaques, or nodules. They can be indistinguishable from each other and a multitude of differential diagnoses, necessitating a better understanding of the characteristics that make the diagnosis of poroid neoplasms. However, there remains a paucity of information on these lesions, especially DDTs, given their infrequent occurrence. Herein, we review the literature on DDTs with an emphasis on epidemiology, pathogenesis, clinical features, diagnosis, and management.

1 October 2018 in Journal of Cutaneous Pathology
Verified
Journal Article
Open access
PDF file
PGPavandeep Gill
Pavandeep Gill
MDMarie S. Abi Daoud
Marie S. Abi Daoud
Cellular neurothekeoma is a benign cutaneous neoplasm that typically occurs on the head, neck, and upper body of young adults with a slight female predominance. It is a rare lesion to diagnose and multiple neurothekeomas in one patient are even more uncommon finding. We present a case of multiple neurothekeomas in a middle‐aged woman with lower extremity involvement and summarize the current literature on multiple neurothekeoma patients. A 46‐year‐old female presented with nearly one dozen skin‐colored papules on the head, upper limb, and lower limb. The lesions were clinically diagnosed as dermatofibromas and a nevus. Eight lesions were biopsied and confirmed to be cellular neurothekeomas, with one initially misinterpreted on histology as a dermatofibroma. Awareness of cellular neurothekeoma as a diagnostic entity and the possibility of atypical presentations as seen in our case (eg, in multiple numbers, in older adults, and on the lower extremity) are important in allowing for accurate clinical and histological diagnosis of these lesions. The possibility of a syndromic association with multiple cellular neurothekeomas should be explored further.